| | | 00640 | | 02.10.2000 | | GlaxoSmithKline AG | | | | | | | | | | | | | 08.08. | | | | 08.08. | | IP |
| | Seq.-No. | Product | Description | Galenic form | ATC-classification | |
|---|
| 01 | Infanrix hexa | Pulver und Suspension zur Herstellung einer Injektionssuspension | Injection suspension () + Injection suspension ( 30U.I. / 0.5ml, 40U.I. / 0.5ml, 25µg / 0.5ml, 25µg / 0.5ml, 8µg / 0.5ml, 40U.I. / 0.5ml, 8U.I. / 0.5ml, 32U.I. / 0.5ml, 10µg / 0.5ml) | J07CA09 | | | 02 | Infanrix hexa | | ( 0 UI, 0 UI, 25 mcg, 25 mcg, 8 mcg, 40 UI, 8 UI, 32 UI, 10 mcg, 10 mcg) | | | | 03 | Infanrix hexa | | ( 30 UI, 40 UI, 25 mcg, 25 mcg, 8 mcg, 40 UI, 8 UI, 32 UI, 10 mcg, 10 mcg) | | |
|
|
